Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06774885 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Role of Folic Acid in the Management of Adjuvant Endocrine Therapy-Induced Hot Flashes in Breast Cancer Patients

StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Completed without a posted recruiting period Show 6 more changesShow less
    • Primary completion date changed from estimate of Aug 2025 to Oct 22, 2025
    • Study sites: 0 to 1
    • Start date changed from estimate of Feb 9, 2025 to Apr 5, 2025
    • Eligibility criteria expanded, about 14 words
    • Study description expanded, about 9 words
    • Collaborators expanded, about 4 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study aims to assess the efficacy of folic acid supplementation at two doses (1 mg/day and 5 mg/day) in the management of hot flashes associated with adjuvant endocrine therapy among premenopausal breast cancer patients.
Trial Details
NCT Number NCT06774885
Lead Sponsor Future University in Egypt
Collaborators: National Cancer Institute, Cairo
Conditions
(from sponsor)		 THERAPY-INDUCED HOT FLASHES IN BREAST CANCER PATIENTS
Related terms Breast Neoplasms, Hot Flashes
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov